AAAAAA

   
Results: 1-3 |
Results: 3
DIFFERENTIAL EFFECT OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN ON INTRAVASCULAR TISSUE FACTOR PATHWAY INHIBITOR - EVIDENCE FOR A DIFFERENCE IN ANTITHROMBOTIC ACTION
Authors: HANSEN JB SANDSET PM HUSEBY KR HUSEBY NE BENDZ B
Citation: Jb. Hansen et al., DIFFERENTIAL EFFECT OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN ON INTRAVASCULAR TISSUE FACTOR PATHWAY INHIBITOR - EVIDENCE FOR A DIFFERENCE IN ANTITHROMBOTIC ACTION, British Journal of Haematology, 101(4), 1998, pp. 638-646
TISSUE FACTOR PATHWAY INHIBITOR - CLINICAL DEFICIENCY STATES
Authors: SANDSET PM BENDZ B
Citation: Pm. Sandset et B. Bendz, TISSUE FACTOR PATHWAY INHIBITOR - CLINICAL DEFICIENCY STATES, Thrombosis and haemostasis, 78(1), 1997, pp. 467-470
PARTIAL DEPLETION OF TFPI DURING SC ADMINISTRATION OF UNFRACTIONATED HEPARIN BUT NOT WITH 2 LOW-MOLECULAR-WEIGHT HEPARINS
Authors: BENDZ B HANSEN JB ANDERSEN TO SANDSET PM
Citation: B. Bendz et al., PARTIAL DEPLETION OF TFPI DURING SC ADMINISTRATION OF UNFRACTIONATED HEPARIN BUT NOT WITH 2 LOW-MOLECULAR-WEIGHT HEPARINS, Blood, 90(10), 1997, pp. 1311-1311
Risultati: 1-3 |